<DOC>
	<DOCNO>NCT02526966</DOCNO>
	<brief_summary>The anti-hinge region antibody would relevant biomarker IgA nephropathy . Beyond prognostic value ( could increase risk Renal Absolute ) , longitudinal monitoring antibody could interest : ( 1 ) monitoring patient ( place include possible repetition renal biopsy ) ; ( 2 ) guide treatment decision ( 3 ) clinical research , outcome ( substitution occurrence kidney failure ) therapeutic trial IgA nephropathy . This research project constitute first step validate antibody biomarker IgA nephropathy main objective study performance blood level anti-hinge region antibody diagnosis progressive form histologically IgA nephropathy define Renal Risk Absolute . The secondary objective project establish bio-collection allow u search prognostic factor ( genetic , cellular serum ) IgA nephropathy evaluate performance Renal Absolute risk integrate Oxford score , new international histological classification .</brief_summary>
	<brief_title>Multicenter Study Evaluating Performance Assay Anti-hinge Region Antibodies Diagnosis Progressive Forms IgA Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Major Patient Diagnosis primitive form IgA nephropathy histologically proven Suspicion secondary IgA nephropathy form Less 5 glomeruli present renal biopsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>